Opendata, web and dolomites

Horizon2020 projects coordinated by "GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL"

# project acronym  year  total cost  totalcontribution 
1 ANTBIOTIC AnTBiotic – progressing TB drug candidates to clinical proof of concept 2017 5˙819˙416.00 5˙819˙416.00
2 LYMPHVECS Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease 2019 158˙121.00 158˙121.00

More Horizon 2020 projects

The Institution GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL has been involved also in the following Horizon 2020 projects.